Scancell
Transformational £15m capital raise closesHutchison China MediTech
Innovative pipeline closer to realising its potentialScancell
Material fund raise means clinical progress in sightMaxCyte
New products, new deals, attractive prospectsFutura Medical
FDA green lights MED3000 for OTC approvalMaxCyte
Apeiron licence broadens the MaxCyte opportunityBerGenBio
AXL-erating towards new opportunitiesFutura Medical
AGM statement confirms MED3000 filings on trackBonesupport
Swings and roundaboutsHutchison China MediTech
General Atlantic invests $100m at 10% premium